Pylarify QTY 80
Active Awarded Last action
- Contract number
- 36C24724F0045
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,091,449
Award facts
- Contract value 65% obligated
-
- $2,091,448.88 Current, with exercised options
- $3,210,152.08 Potential, with all options
- Completion date 59% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $360,872 | |
| Supplemental Agreement for work within scope | -$12,435 | |
| Supplemental Agreement for work within scope | -$7,217 | |
| Exercise an Option | $559,352 | |
| Supplemental Agreement for work within scope | $126,305 | |
| Supplemental Agreement for work within scope | $270,654 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $288,698 | |
| Other Administrative Action | $108,262 | |
| Other Administrative Action | $108,262 | |
| Original award | $288,698 |
Show all 11
About this award
Veterans Integrated Service Network 7 issued a delivery order to Progenics Pharmaceuticals Inc. on November 1, 2023, for 80 units of PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent, with a ceiling value of $3,210,152.08 and firm fixed-price terms. The order is issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
Place of performance is North Billerica, Billerica, MA. The ultimate completion date is October 31, 2028. PYLARIFY is a positron emission tomography imaging agent used for prostate cancer detection and localization in federal healthcare settings. Progenics Pharmaceuticals Inc. is a division of Lantheus Medical Imaging, Inc. and operates as the sole authorized manufacturer of PYLARIFY for federal procurement.
Quick answers
Who was awarded contract 36C24724F0045?
36C24724F0045 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on November 1, 2023.
How much is contract 36C24724F0045 worth?
The government has obligated $2,091,449 on 36C24724F0045. Its potential value, with all options, is $3,210,152.
Is contract 36C24724F0045 an order under another contract?
Yes. 36C24724F0045 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24724F0045 competed?
The extent of competition for 36C24724F0045 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award